No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Clinical Trials, Phase I as Topic
-
Clinical Trials, Phase II as Topic
-
Enzyme Inhibitors / adverse effects
-
Enzyme Inhibitors / therapeutic use*
-
Gastrointestinal Neoplasms / drug therapy*
-
Humans
-
Imatinib Mesylate
-
Piperazines / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Sarcoma / drug therapy*
Substances
-
Antineoplastic Agents
-
Benzamides
-
Enzyme Inhibitors
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate